Skip to main content
Fabrazyme 5 mg/mL injection, powder, lyophilized, for solution by Genzyme Corporation
Fabrazyme, 5 mg/mL, injection, powder, lyophilized, for solution Drug class: Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme. Available on prescription only. Listed by Genzyme Corporation.
Prescription only

Fabrazyme

AGALSIDASE BETA

Listed by Genzyme Corporation

Strength
5 mg/mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Class
Hydrolytic Lysosomal Neutral Glycosphingolipi…

What it contains

  • Agalsidase Beta 5 mg/mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Drug class Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
Approval route BLA — biologic licence
NDC code 58468-0041
FDA application BLA103979
RxNorm concept 1804755
Package sizes listed 1
Marketed since December 2008

Other products containing Agalsidase Beta

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Fabrazyme

AGALSIDASE BETA

Strength
5 mg/mL
Form
Injection, Powder, Lyophilized, For Solution
Class
Hydrolytic Lysosomal Neutral Glycosphin…
Rx only

Genzyme Corporation

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.